Key references: Hormonal treatment for endometriosis
Abou-Setta AM, Houston B, Al-Inany HG, Farquhar C. Levonorgestrel-releasing intrauterine device (LNG-IUD) for symptomatic endometriosis following surgery. Cochrane Database Syst Rev 2013;(1):CD005072. https://www.ncbi.nlm.nih.gov/pubmed/23440798
Baldaszti E, Wimmer-Puchinger B, Loschke K. Acceptability of the long-term contraceptive levonorgestrel-releasing intrauterine system (Mirena): a 3-year follow-up study. Contraception 2003;67(2):87–91. https://www.ncbi.nlm.nih.gov/pubmed/12586318
Bedaiwy MA, Allaire C, Alfaraj S. Long-term medical management of endometriosis with dienogest and with a gonadotropin-releasing hormone agonist and add-back hormone therapy. Fertil Steril 2017;107(3):537–48. https://www.ncbi.nlm.nih.gov/pubmed/28139239
Bergqvist A, Group S. A comparative study of the acceptability and effect of goserelin and nafarelin on endometriosis. Gynecol Endocrinol 2000;14(6):425–32. https://www.ncbi.nlm.nih.gov/pubmed/11228063
Carvalho N, Margatho D, Cursino K, Benetti-Pinto CL, Bahamondes L. Control of endometriosis-associated pain with etonogestrel-releasing contraceptive implant and 52-mg levonorgestrel-releasing intrauterine system: randomized clinical trial. Fertil Steril 2018;110(6):1129–36. https://www.ncbi.nlm.nih.gov/pubmed/30396557
Dunselman GA, Vermeulen N, Becker C, Calhaz-Jorge C, D'Hooghe T, De Bie B, et al. ESHRE guideline: management of women with endometriosis. Hum Reprod 2014;29(3):400–12. https://www.ncbi.nlm.nih.gov/pubmed/24435778
Maiorana A, Incandela D, Parazzini F, Alio W, Mercurio A, Giambanco L, et al. Efficacy of dienogest in improving pain in women with endometriosis: a 12-month single-center experience. Arch Gynecol Obstet 2017;296(3):429–33. https://www.ncbi.nlm.nih.gov/pubmed/28664483
